Answers are grounded in this paper and cite their sources.
CMV is a major cause of disease and mortality in patients undergoing Solid Organ Transplants (SOT) and Hematopoietic Stem Cell Transplants (HSCT). In SOT, CMV infection usually establishes itself in the first three months after transplantation in patients who do not receive prophylaxis.
No takes yet. Share an insight, caveat, or question.
David Tarragó (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: